Restoring
Company overview
Talaris Therapeutics, Inc. is a late-clinical stage cell therapy company developing therapies with the potential to transform the standard of care in solid organ transplantation and severe immune and blood disorders.
Talaris maintains corporate offices in Boston, MA, a GMP cell processing facility in Louisville, KY, and research and development laboratories in Houston, TX.


To transform the standard of care for solid organ transplant recipients and people living with severe immune and blood disorders.


To bring our transformative cell therapies to patients as quickly and safely as possible.
“From our very beginnings through to the present day, Talaris’ central focus has been improving the lives of patients. We’re proud to be leaders in the space of immune tolerance and to be leveraging our Facilitated Allo-HSCT Therapy platform to pioneer new therapeutic options in areas of high unmet medical need.”
– Scott Requadt, CEO of Talaris
Our Name
The name Talaris comes from “talaria” the winged sandals of the Greek messenger God Hermes (Roman Mercury). They were said to be made by the god Hephaestus of imperishable gold and they flew the god as swift as any bird. This imagery aligns with the message of hope we bring to patients living with conditions caused by immune intolerance.